Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.
We determined the prevalence of hepatitis C virus (HCV) in hemodialysis patients by antibody testing and HCV RNA determination by PCR. A total of 149 patients with kidney failure with replacement therapy were tested. The prevalence of anti-HCV was 6.7% (10 of 149 patients), and viremia was detectable in 8 of 149 (5%) patients. Three of 149 patients (2%) were anti-HCV negative with detectable HCV RNA.
Méndez-Sánchez
Nahum
N
Department of Biomedical Research and Liver Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, Col. Toriello Guerra, Mexico City, Mexico. nmendez@medicasur.org.mx
Motola-Kuba
Daniel
D
Chavez-Tapia
Norberto C
NC
Bahena
Jesús
J
Correa-Rotter
Ricardo
R
Uribe
Misael
M
D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008800:Mexico / Q000453:epidemiology; D012367:RNA, Viral / Q000302:isolation & purification; D006435:Renal Dialysis / Q000009:adverse effects*
D012367:RNA, Viral